Bladder carcinoma typically involves alterations in several genes including the tumor suppressor genes p53, p63, retinoblastoma (Rb), and p16, as well as oncogenes c-myc and epithelial growth factor (EGFR), which are all associated with aggressive and invasive bladder carcinomas. This evidence concerns the gene MYC and urinary bladder carcinoma.